Update: FDA approves new treatment for metastatic triple-negative breast cancer The FDA approved the use of sacituzumab govitecan-hizy (Trodelvy), a treatment drug for people with metastatic triple-negative breast cancer who have received at least two prior therapies for metastatic disease. (4/27/20) Read the article Printer Friendly Page This article is most relevant for: People with
Topic: COVID-19 and Cancer The current COVID-19 pandemic has led to many changes in our communities. In this XRAY review we focus on the intersection between COVID-19 and cancer: who may be immunosuppressed, coping with changes in surveillance or treatment, and evaluating and dealing with media. (4/13/20) Este artículo está disponible en español. Printer Friendly
Susan G. Komen is hosting a virtual event this summer called In My Own Voice (IMOV) for African American women living with MBC. The program will consist of a welcome and overview webinar, an educational webinar on the latest advancements in MBC research and treatment, and virtual focus group discussion to engage participants in conversations
In 2014, one year after its formation, the Metastatic Breast Cancer Alliance (MBC Alliance) published Changing the Landscape for People Living with Metastatic Breast Cancer. Chapter 5 of the analysis showed a lack of data about the population of metastatic breast cancer (MBC) patients living across the US. The MBC Alliance identified key questions to
‘If I don’t find something that works, I will die’ Women living with metastatic breast cancer often feel isolated and invisible in the larger breast cancer narrative.
